Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 2265-2271, May 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, T. R.
Right arrow Articles by Goldsworthy, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, T. R.
Right arrow Articles by Goldsworthy, T. L.

Gene Expression and Cell Proliferation in Rat Liver after 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure1

Tony R. Fox2, Lang L. Best, Susan M. Goldsworthy, Jeremy J. Mills and Thomas L. Goldsworthy

Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709

Recently 4 genes (plasminogen activator inhibitor 2, interleukin 1ß, clone 1, and clone 141) that are transcriptionally or posttranscriptionally responsive to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) have been cloned from a human skin keratinocyte cell line. We determined whether these genes were expressed in the livers of Sprague-Dawley rats following exposure to TCDD and whether there was a relationship between expression and hepatic cell proliferation. TCDD was administered by using a dose loading/maintenance regimen to achieve rapid quasi-steady-state TCDD liver concentrations of 0.03, 30, or 150 ng/g of liver. Gene expression was determined by Northern analysis using polyadenylated mRNA isolated from liver tissue of male and female animals exposed to TCDD for 1 or 14 days and hybridized with the human complementary DNA clone corresponding to one of the four human TCDD-responsive genes. Under low-stringency hybridization conditions, only the expression of clone 1 could be detected. A dose- and time-dependent expression of this gene was observed in the liver of both male and female rats. Expression of clone 1 was not detected in rats subjected to either a two-thirds partial hepatectomy or exposure to a single administration of the hepatic tumor promoters Wy-14643, carbon tetrachloride, or phenobarbital at doses that induce hepatic cell proliferation. Liver:body weight ratios were elevated in rats exposed to the middle and high TCDD doses. Histopathological observation and analysis of serum enzyme levels indicated no evidence of TCDD-induced liver necrosis. Cell proliferation was evaluated immunohistochemically after 7-day 5-bromo-2'-deoxyuridine administration. No increase in total hepatic labeling index was observed for any of the TCDD-exposed treatment groups compared to controls at week 1 or week 2. An increase in the periportal hepatocyte proliferation labeling pattern was observed in TCDD-treated animals. While these results demonstrate that a human TCDD-responsive gene is expressed in the liver of TCDD-treated male and female Sprague-Dawley rats, the expression of this gene is not linked to hepatic cell proliferation or the sex-specific tumor-promoting activity of TCDD.

1 Partially funded by a grant from the American Paper Institute.

2 To whom requests for reprints should be addressed, at Chemical Industry Institute of Toxicology, P. O. Box 12137, Research Triangle Park, NC 27709.

Received 10/ 7/92. Accepted 3/12/93.




This article has been cited by other articles:


Home page
Toxicol SciHome page
M. Chopra, A. M. Dharmarajan, G. Meiss, and D. Schrenk
Inhibition of UV-C Light-Induced Apoptosis in Liver Cells by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
Toxicol. Sci., September 1, 2009; 111(1): 49 - 63.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S. Burkhardt, R. Bahnemann, K. Failing, and M. Reinacher
Zonal Distribution of Cell Proliferation in the Liver of Untreated B6C3F1 and C57BL Mice
Toxicol Pathol, January 1, 2004; 32(1): 100 - 105.
[Abstract] [PDF]


Home page
Toxicol SciHome page
M. Haag-Gronlund, R. Conolly, G. Scheu, L. Warngard, and R. Fransson-Steen
Analysis of Rat Liver Foci Growth with a Quantitative Two-Cell Model after Treatment with 2,4,5,3',4'-Pentachlorobiphenyl
Toxicol. Sci., September 1, 2000; 57(1): 32 - 42.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. K. Dienhart, R. J. Sommer, R. E. Peterson, A. N. Hirshfield, and E. K. Silbergeld
Gestational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Developmental Defects in the Rat Vagina
Toxicol. Sci., July 1, 2000; 56(1): 141 - 149.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
M. E Andersen and R. B Conolly
Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin
Human and Experimental Toxicology, December 1, 1998; 17(12): 683 - 690.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.